TBC1D19 Antibodies

Santa Cruz Biotechnology delivers a wide array of TBC1D19 monoclonal antibodies for research in understanding TBC1D19's role in cellular processes. TBC1D19 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TBC1D19 belongs to the TBC (Tre-2/Bub2/CDC16) domain family, which plays a significant role in regulating intracellular trafficking and endosomal dynamics. TBC1D19 functions are essential in cellular signaling and membrane transport, influencing processes such as autophagy and lysosomal function. Research has shown TBC1D19's involvement in various biological pathways, making it a crucial target for studying disease mechanisms. Understanding TBC1D19 has become increasingly important for investigating its role in neurodegenerative disorders and cancer development. Exploring TBC1D19's molecular interactions can provide valuable insights into cellular regulation and disease progression. Current research continues to uncover new aspects of TBC1D19's biological functions and potential therapeutic implications. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of TBC1D19's role in health and disease.